Cargando…
General practitioner perception of prostate-specific antigen testing has improved, but more awareness of prostate cancer risk in younger patients is still awaited
BACKGROUND: In 2006, a county-wide survey of general practitioners (GPs) in the United Kingdom (UK) identified a reluctance to refer younger men with abnormal prostate specific antigen (PSA) levels. Younger men have the most to gain from early-detection of prostate cancer (PCa), which remains a nati...
Autores principales: | Thurtle, David R., Gordon, Emma M., Brierly, Robert D., Conway, Ciaran J., McLoughlin, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004706/ https://www.ncbi.nlm.nih.gov/pubmed/29922634 http://dx.doi.org/10.1016/j.prnil.2017.10.001 |
Ejemplares similares
-
ALS Treatment- We Still Await the “Magic Cocktail”
por: Koh, Jasmine Shimin, et al.
Publicado: (2022) -
New Concepts in the Investigation and Treatment of Prostatic Hyperplasia
por: McLoughlin, J.
Publicado: (1992) -
What predicts emotional response in men awaiting prostate biopsy?
por: Groarke, AnnMarie, et al.
Publicado: (2018) -
Validation of continuous cardiac output technologies: consensus still awaited
por: Cecconi, Maurizio, et al.
Publicado: (2009) -
Urinary prostate specific antigen, usefulness is still a matter of controversy
por: Hekal, Ihab Ahmed
Publicado: (2013)